Cargando…

Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies

Crystallography provides structural information crucial for fragment optimization, however several criteria must be met to screen directly on protein crystals as soakable, well‐diffracting specimen must be available. We screened a 96‐fragment library against the tRNA‐modifying enzyme TGT using cryst...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassaan, Engi, Eriksson, Per‐Olof, Geschwindner, Stefan, Heine, Andreas, Klebe, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687107/
https://www.ncbi.nlm.nih.gov/pubmed/31808981
http://dx.doi.org/10.1002/cmdc.201900604
_version_ 1783613458086887424
author Hassaan, Engi
Eriksson, Per‐Olof
Geschwindner, Stefan
Heine, Andreas
Klebe, Gerhard
author_facet Hassaan, Engi
Eriksson, Per‐Olof
Geschwindner, Stefan
Heine, Andreas
Klebe, Gerhard
author_sort Hassaan, Engi
collection PubMed
description Crystallography provides structural information crucial for fragment optimization, however several criteria must be met to screen directly on protein crystals as soakable, well‐diffracting specimen must be available. We screened a 96‐fragment library against the tRNA‐modifying enzyme TGT using crystallography. Eight hits, some with surprising binding poses, were detected. However, the amount of data collection, reduction and refinement is assumed substantial. Therefore, having a reliable cascade of fast and cost‐efficient methods available for pre‐screening before embarking to elaborate crystallographic screening appears beneficial. This allows filtering of compounds to the most promising hits, available to rapidly progress from hit‐to‐lead. But how to ensure that this workflow is reliable? To answer this question, we also applied SPR and NMR to the same screening sample to study whether identical hits are retrieved. Upon hit‐list comparisons, crystallography shows with NMR and SPR, only one overlapping hit and all three methods shared no common hits. This questions a cascade‐type screening protocol at least in the current example. Compared to crystallography, SPR and NMR detected higher percentages of non‐active‐site binders suggesting the importance of running reporter ligand‐based competitive screens in SPR and NMR, a requirement not needed in crystallography. Although not specific, NMR proved a more sensitive method relative to SPR and crystallography, as it picked up the highest numbers of binders.
format Online
Article
Text
id pubmed-7687107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76871072020-12-03 Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies Hassaan, Engi Eriksson, Per‐Olof Geschwindner, Stefan Heine, Andreas Klebe, Gerhard ChemMedChem Full Papers Crystallography provides structural information crucial for fragment optimization, however several criteria must be met to screen directly on protein crystals as soakable, well‐diffracting specimen must be available. We screened a 96‐fragment library against the tRNA‐modifying enzyme TGT using crystallography. Eight hits, some with surprising binding poses, were detected. However, the amount of data collection, reduction and refinement is assumed substantial. Therefore, having a reliable cascade of fast and cost‐efficient methods available for pre‐screening before embarking to elaborate crystallographic screening appears beneficial. This allows filtering of compounds to the most promising hits, available to rapidly progress from hit‐to‐lead. But how to ensure that this workflow is reliable? To answer this question, we also applied SPR and NMR to the same screening sample to study whether identical hits are retrieved. Upon hit‐list comparisons, crystallography shows with NMR and SPR, only one overlapping hit and all three methods shared no common hits. This questions a cascade‐type screening protocol at least in the current example. Compared to crystallography, SPR and NMR detected higher percentages of non‐active‐site binders suggesting the importance of running reporter ligand‐based competitive screens in SPR and NMR, a requirement not needed in crystallography. Although not specific, NMR proved a more sensitive method relative to SPR and crystallography, as it picked up the highest numbers of binders. John Wiley and Sons Inc. 2020-01-29 2020-02-05 /pmc/articles/PMC7687107/ /pubmed/31808981 http://dx.doi.org/10.1002/cmdc.201900604 Text en © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full Papers
Hassaan, Engi
Eriksson, Per‐Olof
Geschwindner, Stefan
Heine, Andreas
Klebe, Gerhard
Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title_full Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title_fullStr Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title_full_unstemmed Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title_short Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
title_sort fragments as novel starting points for trna‐guanine transglycosylase inhibitors found by alternative screening strategies
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687107/
https://www.ncbi.nlm.nih.gov/pubmed/31808981
http://dx.doi.org/10.1002/cmdc.201900604
work_keys_str_mv AT hassaanengi fragmentsasnovelstartingpointsfortrnaguaninetransglycosylaseinhibitorsfoundbyalternativescreeningstrategies
AT erikssonperolof fragmentsasnovelstartingpointsfortrnaguaninetransglycosylaseinhibitorsfoundbyalternativescreeningstrategies
AT geschwindnerstefan fragmentsasnovelstartingpointsfortrnaguaninetransglycosylaseinhibitorsfoundbyalternativescreeningstrategies
AT heineandreas fragmentsasnovelstartingpointsfortrnaguaninetransglycosylaseinhibitorsfoundbyalternativescreeningstrategies
AT klebegerhard fragmentsasnovelstartingpointsfortrnaguaninetransglycosylaseinhibitorsfoundbyalternativescreeningstrategies